Skip to content
New: 100+ more US companies, including the big banks, plus insider trades from SEC filings

Compare · Consumer Staples

Altria vs. Philip Morris International: how they make money

The same facts for both companies, in the same order, from each company's own page and filings. This is not a ranking and says nothing about which share to own.

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Each company in 5 points

Altria

  1. 1 · What it sells

    Altria sells Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal smokeless tobacco and on! nicotine pouches in the U.S., with net revenues of $23.3 billion in FY2025.

    Sources and detail on the Altria page
  2. 2 · Who pays it

    In FY2025 one unnamed customer paid about 23% of net revenues and another about 19%, and other wholesalers, distributors and retail chains paid the remaining 58%.

    Sources and detail on the Altria page
  3. 3 · What it keeps from $100

    Of every $100 that came in during FY2025, Altria kept $29.1 as net income after $9.0 of mostly NJOY impairment and exit costs, and operating income without those costs was $51.7 per $100 of net revenues.

    Sources and detail on the Altria page
  4. 4 · Where the operating profit comes from

    In FY2025 smokeable products earned $10,984 million of segment operating income and oral tobacco $1,828 million, while e-vapor lost $2,297 million after $2,128 million of impairments.

    Sources and detail on the Altria page
  5. 5 · The one thing to watch

    Altria's domestic cigarette shipments fell 2.9% in Q3 FY2026, while discount brands' share of U.S. cigarette retail sales rose 2.0 points to 34.1%.

    Sources and detail on the Altria page

Philip Morris International

  1. 1 · What it sells

    Philip Morris International sells Marlboro and other cigarettes outside the US, plus IQOS heated tobacco, ZYN nicotine pouches and VEEV e-vapor, with net revenues of $40.6 billion in FY2025.

    Sources and detail on the Philip Morris International page
  2. 2 · Who pays it

    In FY2025, cigarette buyers outside the US paid 57.7% of PMI's net revenues, smoke-free buyers outside the US 34.4% and US buyers, mainly of ZYN, 7.9%.

    Sources and detail on the Philip Morris International page
  3. 3 · What it keeps from $100

    Of every $100 that came in during FY2025, PMI kept $27.4 as net income, which included income from equity investments and securities, and operating income was $36.6 per $100 of net revenues.

    Sources and detail on the Philip Morris International page
  4. 4 · Where the operating profit comes from

    PMI measures segment profit as gross profit, and in FY2025 International Combustibles earned 56.9% of it, International Smoke-Free 35.1% and the US 8.1%.

    Sources and detail on the Philip Morris International page
  5. 5 · The one thing to watch

    US smoke-free revenue was $758 million in Q3 FY2026, up from $605 million a year earlier, after $543 million in Q1 FY2026, down from $818 million.

    Sources and detail on the Philip Morris International page

Where each $100 went

Each company's own receipt for its latest full fiscal year, with matching lines in the same order where both have them.

Altria

Where $100 went · FY2025

Where $100 of Altria's money went in FY2025
Marketing, administration and research$10.5
State settlement payments and FDA user fees$13.7
Making the products$9.7
Impairment and exit costs (mostly NJOY)$9.0
Interest$4.5
Federal excise taxes$13.2
Income tax$10.2
Kept as net income$29.1
Total$100

Cityfort calculation from FY2025 10-K and Q4 FY2025 earnings release. Of every $100 that came in during FY2025 (net revenues of $23,279 million plus $569 million of investment and pension income): each line = line ÷ $23,848 million × 100. The settlement line is the state settlement charges ($3,028 million) and FDA user fees ($250 million) inside cost of sales; the product line is the rest of cost of sales. Impairment and exit costs include $2,128 million of NJOY e-vapor impairments.

Philip Morris International

Where $100 went · FY2025

Where $100 of Philip Morris International's money went in FY2025
Marketing, administration and research$30.0
Cost of sales$32.3
Net interest and pension costs$2.4
Minority owners' share$1.2
Income tax$6.6
Kept as net income$27.4
Total$100

Cityfort calculation from the FY2025 10-K. Of every $100 that came in during FY2025: each line = line ÷ $41.4 billion (net revenues of $40.6 billion plus $705 million of income from equity investments and securities) × 100. Because of that income, net income here ($27.4) is lower than net income ÷ net revenues ($27.9).

Line items differ because each company groups its costs its own way in its filings. Only on Altria's receipt: Federal excise taxes; State settlement payments and FDA user fees; Making the products; Impairment and exit costs (mostly NJOY); Interest. Only on Philip Morris International's receipt: Cost of sales; Net interest and pension costs; Minority owners' share.

Sources: Altria S1 · Philip Morris International S1

Revenue, net income and free cash flow

Up to five fiscal years for each company, drawn on one shared scale per measure. Amounts in US$ as reported (GAAP).

Revenue

Altria

Philip Morris International

Both charts use the same scale. Each company's own fiscal years.
See the numbers
Revenue of Altria and Philip Morris International by fiscal year, US$
Altria yearAltria revenuePhilip Morris International yearPhilip Morris International revenue
FY2021$26.0BFY2021$31.4B
FY2022$25.1BFY2022$31.8B
FY2023$24.5BFY2023$35.2B
FY2024$24.0BFY2024$37.9B
FY2025$23.3BFY2025$40.6B

Net income

Altria

Philip Morris International

Both charts use the same scale. Each company's own fiscal years.
See the numbers
Net income of Altria and Philip Morris International by fiscal year, US$
Altria yearAltria net incomePhilip Morris International yearPhilip Morris International net income
FY2021$2.5BFY2021$9.1B
FY2022$5.8BFY2022$9.0B
FY2023$8.1BFY2023$7.8B
FY2024$11.3BFY2024$7.1B
FY2025$6.9BFY2025$11.3B

Free cash flow

Altria

Philip Morris International

Both charts use the same scale. Each company's own fiscal years; free cash flow = cash from operations minus capital spending, as on each company's page.
See the numbers
Free cash flow of Altria and Philip Morris International by fiscal year, US$
Altria yearAltria free cash flowPhilip Morris International yearPhilip Morris International free cash flow
FY2021$8.2BFY2021$11.2B
FY2022$8.1BFY2022$9.7B
FY2023$9.1BFY2023$7.9B
FY2024$8.6BFY2024$10.8B
FY2025$9.1BFY2025$10.7B

Sources: Altria S3, S1 · Philip Morris International S2, S3, S1

Who pays each company

Altria

  • Largest customer (not named) · 23.0% of revenueOne customer paid about 23% of FY2025 net revenues, against 22% in FY2024 and 25% in FY2023. Altria sells mainly to wholesalers, including distributors, and large retail chains.
  • Second-largest customer (not named) · 19.0% of revenueAnother customer paid about 19% of FY2025 net revenues, against 20% in FY2024 and 23% in FY2023.
  • Other wholesalers, distributors and retail chains · 58.0% of revenueNo other customer paid 10% or more of net revenues. The rest of FY2025 net revenues, about 58%, came from these buyers (Cityfort calculation from FY2025 10-K).

Philip Morris International

  • Cigarette buyers outside the US · 57.7% of revenueDistributors, wholesalers and retailers buying cigarettes and other combustible tobacco: the International Combustibles segment, $23.4 billion or 57.7% of FY2025 net revenues.
  • Smoke-free buyers outside the US · 34.4% of revenueThe same trade buying IQOS devices and sticks, ZYN, VEEV and wellness products: the International Smoke-Free segment, $14.0 billion or 34.4%.
  • US buyers · 7.9% of revenueThe U.S. segment, $3.2 billion or 7.9%: $2.9 billion of smoke-free products, mainly ZYN, and $358 million of combustible tobacco.

Sources: Altria S1 · Philip Morris International S10, S1

Revenue by segment

Altria

FY2025

Altria revenue by segment, FY2025
SegmentRevenueShare
Smokeable products$20.5B88.0%
Oral tobacco products$2.8B12.0%
Other (e-vapor, wine, all other)−$8M0.0%

Philip Morris International

FY2025 (recast under the segments PMI adopted on Jan 1, 2026)

Philip Morris International revenue by segment, FY2025 (recast under the segments PMI adopted on Jan 1, 2026)
SegmentRevenueShare
International Combustibles$23.4B57.7%
International Smoke-Free$14.0B34.4%
U.S.$3.2B7.9%

Sources: Altria S1, S3 · Philip Morris International S10

Debt and cash

Altria

Debt
$24.1B
Cash and investments
$2.7B

On Sep 30, 2026.

At Sep 30, 2026 Altria owed $24.1 billion and held $2.7 billion of cash; net debt was about 2.3 times its FY2025 cash from operations.

Philip Morris International

Debt
$47.6B
Cash and investments
$6.7B

On Sep 30, 2026.

At Sep 30, 2026 PMI's debt exceeded its cash by $40.9 billion, about 3.3 times its $12.2 billion of cash from operations in FY2025.

Sources: Altria S1, S4, S6 · Philip Morris International S4, S1, S7

Who owns each company

Altria

  • One class of shares.
  • Officers and directors as a group: 0.1% of shares (as of Mar 25, 2026).
  • BlackRock: 7.6% (as of Apr 2, 2026).
  • Vanguard Capital Management: 7.5% (as of Apr 29, 2026).
  • The Vanguard Group: 0.0% (as of Mar 26, 2026).

Philip Morris International

  • One class of shares.
  • Officers and directors as a group: 0.1% of shares (as of Mar 13, 2026).
  • Capital World Investors: 8.2% (as of Mar 31, 2025).
  • Vanguard Capital Management: 7.5% (as of Mar 31, 2026).
  • BlackRock, Inc.: 6.2% (as of Dec 31, 2023).
  • 1 more holders on the Philip Morris International page.

Sources: Altria S14, S4, S21, S20 · Philip Morris International S11, S4, S14, S12, S15

Risks only one page tracks

Risks whose type the other company's page does not list. Both pages track risks of these types: pricing, legal cases, regulation, customer or supplier concentration, debt. Every risk is on each company's page.

Altria

  • Fewer cigarettes sold each year (demand)Altria's U.S. cigarette shipments fell 10.0% in FY2025 to 61.8 billion, and 2.9% in Q3 FY2026. The 10-K lists shifting adult consumer preferences and falling industry volumes as risks; smokeable products were 88.0% of FY2025 net revenues.
  • Illicit e-vapor and the NJOY setback (competition)Altria estimates flavored disposable e-vapor products, most of which it believes have evaded FDA review, are about 70% of the e-vapor category. NJOY ACE has been under ITC orders since Mar 31, 2025, and the 10-K says further e-vapor impairments are possible.
  • The ABI investment (other)Altria wrote down its ABI investment by $6.2 billion in 2021 and $2.5 billion in 2022. Its stake of about 8.1% was carried at $9.0 billion at Sep 30, 2026.

Philip Morris International

  • Business in Russia (other)Russia was about 6% of PMI's 2025 net revenues and 9% of its cigarette and heated tobacco shipments. About $2.3 billion of cash sat there at Dec 31, 2025, mostly in rubles, and PMI says a sale would likely bring a material impairment.
  • Write-downs move net income (other)RBH write-downs cut net income by $2,316 million in FY2024 and $511 million in Q2 FY2026. Fair-value changes on holdings in India and Sri Lanka also move profit: a $339 million after-tax loss in the first nine months of 2026.

Sources: Altria S1, S6, S3, S4 · Philip Morris International S1, S4

Key facts

How does Altria make money compared with Philip Morris International?
Altria's revenue by segment in FY2025: Smokeable products 88.0%, Oral tobacco products 12.0%, Other (e-vapor, wine, all other) 0.0%. Philip Morris International's revenue by segment in FY2025 (recast under the segments PMI adopted on Jan 1, 2026): International Combustibles 57.7%, International Smoke-Free 34.4%, U.S. 7.9%.
Which is bigger by revenue, Altria or Philip Morris International?
Altria reported $23.3B of revenue in FY2025, and Philip Morris International reported $40.6B in FY2025.
How much net income did Altria and Philip Morris International report?
Altria reported net income of $6.9B in FY2025, and Philip Morris International reported $11.3B in FY2025.
How much of every $100 did Altria and Philip Morris International keep as net income?
Altria kept $29.1 of every $100 that came in during FY2025, and Philip Morris International kept $27.4 in FY2025 (Cityfort calculation from each company's annual report).
How much debt and cash do Altria and Philip Morris International have?
Altria had $24.1B of debt and $2.7B of cash and investments on Sep 30, 2026. Philip Morris International had $47.6B of debt and $6.7B of cash and investments on Sep 30, 2026.
When do Altria's and Philip Morris International's fiscal years end?
Altria: Dec 31. Philip Morris International: Dec 31.

Sources: Altria S3, S1, S4, S6 · Philip Morris International S2, S3, S1, S10, S4, S7

Built from each company's page. Altria updated Nov 6, 2026; Philip Morris International updated Nov 6, 2026.

Sources

Altria

  1. S1Form 10-K, fiscal year 2025 (ended Dec 31, 2025), Altria Group, Inc. (SEC EDGAR), Feb 25, 2026
  2. S3Form 10-K, fiscal year 2023 (ended Dec 31, 2023), Altria Group, Inc. (SEC EDGAR), Feb 27, 2024
  3. S4Form 10-Q, Q3 2026 (quarter ended Sep 30, 2026), Altria Group, Inc. (SEC EDGAR), Oct 29, 2026
  4. S6Earnings release, Q3 2026 (Form 8-K, Ex. 99.1), Altria Group, Inc. (SEC EDGAR), Oct 29, 2026
  5. S14Definitive proxy statement (DEF 14A), 2026 annual meeting, Altria Group, Inc. (SEC EDGAR), Apr 2, 2026
  6. S20Schedule 13G/A, The Vanguard Group (event Mar 13, 2026), The Vanguard Group (SEC EDGAR), Mar 26, 2026
  7. S21Schedule 13G, Vanguard Capital Management (event Mar 31, 2026), Vanguard Capital Management (SEC EDGAR), Apr 29, 2026

Philip Morris International

  1. S1Form 10-K, fiscal year 2025 (ended Dec 31, 2025), Philip Morris International Inc. (SEC EDGAR), Feb 6, 2026
  2. S2Form 10-K, fiscal year 2023 (ended Dec 31, 2023), Philip Morris International Inc. (SEC EDGAR), Feb 8, 2024
  3. S3Form 10-K, fiscal year 2022 (ended Dec 31, 2022), Philip Morris International Inc. (SEC EDGAR), Feb 10, 2023
  4. S4Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026), Philip Morris International Inc. (SEC EDGAR), Oct 23, 2026
  5. S7Earnings release, Q3 FY2026 (Form 8-K Ex. 99.1, Oct 21, 2026), Philip Morris International Inc. (SEC EDGAR), Oct 21, 2026
  6. S10Form 8-K Ex. 99.1: recast 2025 vs 2024 results under the new segments (Mar 13, 2026), Philip Morris International Inc. (SEC EDGAR), Mar 13, 2026
  7. S11Definitive proxy statement (DEF 14A), 2026 annual meeting, Philip Morris International Inc. (SEC EDGAR), Mar 26, 2026
  8. S12Schedule 13G, Vanguard Capital Management (event Mar 31, 2026), Vanguard Capital Management (SEC EDGAR), Apr 30, 2026
  9. S14Schedule 13G/A, Capital International Investors (event Mar 31, 2026), Capital International Investors (SEC EDGAR), May 14, 2026
  10. S15Schedule 13G/A, The Vanguard Group (event Mar 13, 2026), The Vanguard Group (SEC EDGAR), Mar 27, 2026

Disclaimer

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.

Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.

Read the positions policy
Read the full disclaimer

Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.

All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.

Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.